These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16154822)

  • 1. Clinical applications of molecular imaging in sarcoma evaluation.
    Hicks RJ; Toner GC; Choong PF
    Cancer Imaging; 2005 Jun; 5(1):66-72. PubMed ID: 16154822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging techniques for evaluation of sarcomas.
    Hicks RJ
    Cancer Imaging; 2005 Jun; 5(1):58-65. PubMed ID: 16154821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
    Tateishi U; Yamaguchi U; Seki K; Terauchi T; Arai Y; Kim EE
    Radiology; 2007 Dec; 245(3):839-47. PubMed ID: 18024454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.
    Tateishi U; Yamaguchi U; Maeda T; Seki K; Terauchi T; Kawai A; Arai Y; Moriyama N; Kakizoe T
    Cancer Sci; 2006 Oct; 97(10):1125-8. PubMed ID: 16925579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
    Gabriel M; Rubello D
    Nucl Med Commun; 2016 Jan; 37(1):3-8. PubMed ID: 26457597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
    Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
    Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and imaging of bone and soft-tissue sarcomas.
    Ilaslan H; Schils J; Nageotte W; Lietman SA; Sundaram M
    Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S2-7. PubMed ID: 20179183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
    Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN; Greene GS
    Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
    Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoma.
    Ceyssens S; Stroobants S
    Methods Mol Biol; 2011; 727():191-203. PubMed ID: 21331935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PET/PET-CT in the management of sarcomas.
    Kumar R; Chauhan A; Vellimana AK; Chawla M
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1241-50. PubMed ID: 16925490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging in Sarcoma.
    Becher S; Oskouei S
    Orthop Clin North Am; 2015 Jul; 46(3):409-15, xi. PubMed ID: 26043054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear medicine techniques provide unique physiologic characterization of suspected and known soft tissue and bone sarcomas.
    Hicks RJ
    Acta Orthop Scand Suppl; 1997 Feb; 273():25-36. PubMed ID: 9057584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, investigations and staging of soft-tissue sarcoma.
    Rock MG
    Can J Surg; 1988 Nov; 31(6):385-9. PubMed ID: 3179847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue sarcomas: a plea for proper management.
    Munk PL; Vellet AD; Bramwell V; Bell R; Hammond A; Beauchamp C
    Can J Surg; 1993 Apr; 36(2):178-80. PubMed ID: 8472231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.